REGENERON PHARMACEUTICALS, INC.: accounts_receivable
| Value | {"amount": 1431966000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2016-06-30) |
| Status | current |
| Entity | REGENERON PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:39:06.709867+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/f78cfeb7-8f7a-4729-90f4-7cb1e2733012
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001532176-16-000067Retrieved: 2026-08-19T08:39:06.709867+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000872589/accounts-receivable/2016-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/f78cfeb7-8f7a-4729-90f4-7cb1e2733012
History
- no predecessors — first report